LW2-17862-59481
2 vaccinations
1 coded response
20 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 800 / CO
- Registered
- 2021-04-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-21
Registered in v-safe
-
2021-04-21
Dose 1 — Pfizer-BioNTech
- 2021-04-21
-
2021-04-22
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-04-23
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-04-24
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Chills, Fatigue or tiredness, Nausea, DiarrheaAdult check-in
- 2021-04-25
- 2021-04-26
- 2021-04-27
- 2021-05-05
-
2021-05-12
Dose 2 — Pfizer-BioNTech
- 2021-05-12
-
2021-05-13
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness · Headache, Fatigue or tirednessAdult check-in
- 2021-05-15
- 2021-05-16
- 2021-05-18
- 2021-05-28
- 2021-06-02
- 2021-06-09
- 2021-06-16
- 2021-08-11
- 2021-11-11
-
2022-05-12
Survey response — 12 months, dose 2MedDRA: Condition aggravated, Hypersensitivity, Pre-existing disease — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: GI issues have worsened. Seasonal allergy symptoms have worsened.MedDRA releases: 2024-11 · check-in free text available
-
2022-05-12
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-05-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-21 | Pfizer-BioNTech | |
| 2 | 2021-05-12 | Pfizer-BioNTech |
Call center
1 call center case
1 unsuccessful
Free text
Release 11 — 12 months, dose 2
Symptoms: GI issues have worsened. Seasonal allergy symptoms have worsened.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Condition aggravated | · | · | ✓ |
| SD | Hypersensitivity | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release